Mechanism of Action of the Angiostatic Cortisene Anecortave Acetate
Author:
- 1 January 2007
- journal article
- review article
- Published by Elsevier in Survey of Ophthalmology
- Vol. 52 (1) , S26-S34
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Insulin-like growth factor-1 contributes to neovascularization in age-related macular degenerationBiochemical and Biophysical Research Communications, 2004
- Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography studyBritish Journal of Ophthalmology, 2004
- Inhibition of experimental choroidal neovascularization in rats by an av-integrin antagonistCurrent Eye Research, 2004
- Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degenerationOphthalmology, 2003
- Periocular Injection of Microspheres Containing PKC412 Inhibits Choroidal Neovascularization in a Porcine ModelInvestigative Ophthalmology & Visual Science, 2003
- ANECORTAVE ACETATE AS MONOTHERAPY FOR THE TREATMENT OF SUBFOVEAL LESIONS IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD)Retina, 2003
- Antiangiogenesis agentsOphthalmology Clinics of North America, 2002
- PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2002
- The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growthNature, 1994
- Interferon alpha‐2a treatment of patients with subfoveal neovascular macular degenerationActa Ophthalmologica, 1993